-
-
Call more information
660-596-2224 -
Authors: Hyundeok Joo, MD, MAS et al ASA Monitor September 2023, Vol. 87, 1–7. Durable, functionally impactful, and subjectively evident cognitive decline is a feared outcome of anesthesia and surgery, particularly for older adults (Br J Anaesth 2017;118:486-8). We need to look no further than Dr. Daniel Cole, a coauthor of this article and the editor […]
Read MoreAuthor: Mary Dale Peterson, MD, MHA, FACHE, FASA ASA Monitor September 2023, Vol. 87, 11. As a health care executive (HCE), I know first-hand the challenges nearly every hospital and health system faces in today’s constrained environment. While some of the issues may vary regionally, many institutions are having to do more with less due to […]
Read MoreAuthors: Dibash Kumar Das, PhD; Steven Shafer, MD, FASA ASA Monitor September 2023, Vol. 87, 1–4. Hosting the 95th Academy Awards, Jimmy Kimmel opened his monologue by saying, “Everybody looks so great! When I look around this room, I can’t help but wonder, ‘Is Ozempic right for me?’” Semaglutide (Ozempic, Wegovy, and Rybelsus) is blowing up social media […]
Read MoreAuthor: Alexander A. Hannenberg, MD ASA Monitor September 2023, Vol. 87, 1–4. For decades, patient monitoring with oximetry and capnography has been an ASA standard of care. It is linked with our specialty’s benchmark improvement in outcomes. Yet even now, these tools remain largely unavailable across low- and middle-income countries. Lifebox was founded in 2011 to […]
Read MoreASA Monitor September 2023, Vol. 87, 15–32. Men die from overdose at greater rates than women A new study, analyzing data from 2020–21, found that men are two to three times more likely to die from overdose in the United States than women. It has long been known that men abuse drugs at higher rates […]
Read More